Securities America’s problems over its involvement with defunct Medical Capital, a California lender, just became more complicated, as Bernstein Liebhard, a New York City law firm, pursues a potential suit against the independent broker dealer.
Bernstein Liebhard announced Wednesday that it is investigating allegations that Securities America fraudulently sold $750 million in private placement notes through Medical Capital from 2003 through 2008, the company said in a statement issued Wednesday morning. According to Liebhard’s statement, Securities America was one of the biggest distributors of Medical Capital notes, and it caused investors to lose more than $1 billion on the investments. In July 2009, the Securities and Exchange Commission charged Medical Capital and two of its executives with securities fraud.
Register or login for access to this item and much more
All Financial Planning content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access